Systematic epitope analysis of the p26 EIAV core protein

Journal of Molecular Recognition

Volumn 20, Issue 4, 2007, Pages 227-237

  Soutullo, Adriana ^b,c   Santi, María N ^a   Perin, Juan C ^a   Beltramini, Leila M ^d   Borel, Ileana Malan ^c   Frank, Ronald ^e   Tonarelli, Georgina G ^a,c  

^a Laboratorio de Parasitología   (Argentina)

^b Laboratorio de Inmunoquímica   (Argentina)

^c UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Circular dichroism; Conformation; ELISA; Epitope analysis; Equine anemia virus; Molecular recognition; p26 core protein; Spot synthesis

Indexed keywords

CORE PROTEIN; EQUINE INFECTIOUS ANEMIA VIRUS, P26; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; EPITOPE MAPPING; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PROTEIN MICROARRAY; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; EPITOPE MAPPING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN ARRAY ANALYSIS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; VIRAL CORE PROTEINS;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS;

EID: 34948855479     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.825     Document Type: Article

References (65)

1. Ball JM, Henry NL, Montelaro RC, Newman MJ. 1994. A versatile synthetic peptide-based ELISA for identifying antibody epitopes. J. Immunol. Methods 171: 37-44.
2. Birkett AJ, Yelamos B, Rodriguez-Crespo I, Gavilanes F, Peterson DL. 1997. Cloning, expression, purification and characterization of the major core protein (p26) from equine infectious anemia virus. Biochim. Biophys. Acta 1339: 62-72.
3. Bürki F, Rossmanith W, Rossmanith E. 1992. Equine lentivirus, comparative studies on four serological tests for the diagnosis of equine infectious anaemia. Vet. Microbiol. 33: 353-360.
4. Chong YH, Payne SL, Issel CJ, Montelaro RC, Rushlow KE. 1991. Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus. J. Virol. 65: 1007-1012.
5. Clements JE, Gdovin SL, Montelaro RC, Narayan O. 1988. Antigenic variation in lentiviral diseases. Annu. Rev. Immunol. 6: 139-159.
6. Coggins L, Norcross NL, Nusbaum SR. 1972. Diagnosis of equine infectious anemia by immunodiffusion test. Am. J. Vet. Res. 33: 11-18.
7. del Alamo M, Neira JL, Mateu MG. 2003. Thermodynamic dissection of a low affinity protein-protein interface involved in human immunodeficiency virus assembly. J. Biol. Hem. 278: 27923-27929.
8. DeLano WL. 2004. The PyMOL Molecular Graphics System. DeLano Scientific: San Carlos, CA; (http://www.pymol.org).
9. Dyson HJ, Wright PE. 1995. Antigenic peptides. FASEB J. 9: 37-42.
10. Egberink HF, Ederveen J, Montelaro RC, Pedersen NC, Horzinek MC, Koolen MJ. 1990. Intracellular proteins of feline immunodeficiency virus and their antigenic relationship with equine infectious anaemia virus proteins. J. Gen. Virol. 71: 739-743.
11. Ellman GL. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82: 70-77.
12. Ferns RB, Partridge JC, Spence RP, Hunt N, Tedder RS, Ferns RB, Partridge JC, Spence RP, Hunt N, Tedder RS. 1989. Epitope location of 13 anti-gag HIV-1 monoclonal antibodies using oligopeptides and their cross-reactivity with HIV-2. AIDS 3: 829-834.
13. Ferns RB, Tedder RS, Weiss RA. 1987. Characterization of monoclonal antibodies against the human immunodeficiency virus gag products and their use in monitoring HIV isolate variation. J. Gen. Virol. 68: 1543-1551.
14. Frank R. 1992. Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48: 9217-9232.
15. Frank R. 2002. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods 267: 13-26.
16. Frank R, Overwin H. 1996. SPOT-synthesis: epitope analysis with arrays of synthetic peptides prepared on cellulose membranes. In Methods in Molecular Biology. Epitope Mapping Protocols, vol. 66, Morris GE (ed.), Humana Press: Totowa; 149-169.
17. Franke L, Grunow R, Meissner R, Portsman T, von Baehr R. 1992. Inhibition of HIV-1 infection in vitro by murine monoclonal anti-p24 antibodies. J. Med. Virol. 37: 137-142.
18. Fraser DG, Leib SR, Zhang BS, Mealey RH, Brown WC, McGuire TC. 2005. Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge. Clin. Diagn. Lab. Immunol. 12: 983-993.
19. Fraser DG, Mealey RH, McGuire TC. 2003. Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides. Immunogenetics 55: 508-514.
20. Fraser DG, Oaks JL, Brown WC, McGuire TC. 2002. Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus. Immunology 105: 295-305.
21. Gamble TR, Yoo S, Vajdos FF, Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist Wl, Hill CP. 1997. Structure of the carboxyl-terminal dimerisation domain of the HIV-1 capsid protein. Science 278: 849-853.
22. Garay A, Rodrigues D, Burton G, Tonarelli G. 2001. Dinámica molecular de un péptido sintético antigénico derivado del virus AIE en agua. FABICIB 5: 9-15.
23. Garzon MT, Lidon-Moya MC, Barrera FN, Prieto A, Gomez J, Mateu MG, Neira JL. 2004. The dimerization domain of the HIV-1 capsid protein binds a capsid protein-derived peptide: a biophysical characterization. Protein Sci. 13: 1512-1523.
24. Grund CH, Lechman ER, Issel CJ, Montelaro RC, Rushlow KE. 1994. Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus. J. Gen. Virol. 75: 657-662.
25. Hammond SA, Cook SJ, Lichtenstein DL, Issel CJ, Montelaro RC. 1997. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71: 3840-3852.
26. Hausdorf G, Gewiess A, Wray V, Porstmann TJ. 1994. A recombinant human immunodeficiency virus type-1 capsid protein (rp24): its expression, purification and physicochemical characterization. J. Virol Methods 50: 1-9.
27. Hinkula J, Rosen J, Sundqvist VA, Stigbrand T, Wahren B. 1990. Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Mol. Immunol. 27: 395-403.
28. Hussain KA, Issel CJ, Rwambo PM, Arnizaut AB, Ball JM, Schnorr KL, Montelaro RC. 1988. Identification of gag precursor of equine infectious anaemia virus with monoclonal antibodies to the major viral core protein, p26. J Gen. Virol. 69: 1719-1724.
29. Janvier B, Archinard P, Mandrand B, Goudeau A, Barin F. 1990. Linear B-cell epitopes of the major core protein of human immunodeficiency virus types 1 and 2. J. Virol. 64: 4258-4263. Author's correction, J. Virol. 66: 613, 1992.
30. Jin Z, Jin L, Peterson DL, Lawson CL. 1999. Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J. Mol. Biol. 286: 83-93.
31. Kaiser E, Colescott RL, Bossinger CD, Cook PI. 1970. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34: 595-598.
32. Kong XG, Pang H, Sugiura T, Matsumoto Y, Onodera T, Akashi H. 1998. Evaluation of equine infectious anemia virus core proteins produced in a baculovirus expression system in agar gel immunodiffusion test and enzyme-linked immunosorbent assay. J. Vet. Med. Sci. 60: 1361-1362.
33. Kong XG, Pang H, Sugiura T, Sentsui H, Onodera T, Matsumoto Y, Akashi H. 1997. Application of equine infectious anemia virus core proteins produced in a baculovirus expression system to serological diagnosis. Microbiol. Immunol. 41: 975-980.
34. Krchnák V, Vágner J, Safer P, Lebl M. 1988. Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator. Collect. Czechoslov. Chem. Commun. 53: 2542-2548.
35. Lonning SM, Zang W, McGuire TC. 1999. Gag protein epitopes recognized by CD4+ T-helper lymphocytes from equine infectious anemia virus-infected carrier Horses. J. Virol. 75: 4257-4265.
36. Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G. 2004. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins. Rev. Argent. Microbiol. 36: 151-157.
37. Lottersberger J, Salvetti JL, Tonarelli G. 2003. Desarrollo y evaluación de péptidos sintéticos para la detección de anticuerpos anti-VIH. Rev. Argent. Microbiol. 35: 149-155.
38. Mammano F, Ohagen A, Hoglund S, Gottlinger HG. 1994. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. Virol. 68: 4927-4936.
39. Mateu MG. 2002. Conformational stability of dimeric and monomeric forms of the C-terminal domain of human immunodeficiency virus-1 capsid protein. J. Mol. Biol. 318: 519-531.
40. McDermott J, Farrell L, Ross R, Barklis E. 1996. Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents. J. Virol. 70: 5106-5114.
41. McGuire TC, Fraser DG, Mealey RH. 2004. Cytotoxic T lymphocytes in protection against equine infectious anemia virus. Anim. Health Res. Rev. 5: 271-276.
42. McGuire T, Leib SR, Lonning SM, Zhang W, Byrne KM, Mealey R. 2000. Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. J. Gen. Virol. 81: 2735-2739.
43. McGuire TC, Tumas DB, Byrne KM, Hines MT, Leib SR, Brassfield AL, O'Rourke KI, Perryman LE. 1994. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J. Virol. 68: 1459-1467.
44. Miller RJ, Cairns JS, Bridges S, Sarver NJ. 2000. Human immunodeficiency virus and AIDS: insights from animal lentiviruses. J. Virol. 74: 7187-7195.
45. Misselwitz R, Hausdorf G, Welfle K, Hohne WE, Welfle H. 1995. Conformation and stability of recombinant HIV-1 capsid protein p24 (rp24). Biochim. Biophys. Acta 1250: 9-18.
46. Montelaro RC, Parekh B, Orrego A, Issel CJ. 1984. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J. Biol. Chem. 259: 10539-10544.
47. Montelaro RC, Robey WG, West MD, Issel CJ, Fischinger PJ. 1988. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J. Gen. Virol. 69: 1711-1717.
48. Nakamura Y, Kameoka M, Tobiume M, Kaya M, Ohki K, Yamada T, Ikuta K. 1997. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein. Vaccine 15: 489-496.
49. Niedrig M, Hinkula J, Harthus HP, Broker M, Hopp L, Pauli G, Wahren B. 1991. Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2. J. Virol. 65: 4529-4533.
50. Niedrig M, Hinkula J, Weigelt W, L'age-Stehr J, Pauli G, Rosen J, Wahren B. 1989. Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides. Virol. 63: 3525-3528.
51. Olmsted RA, Hirsch VM, Purcell RH, Johnson PR. 1989. Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc. Natl. Acad. Sci. USA 86: 8088-8092.
52. Payne S, Parekh B, Montelaro RC, Issel CJ. 1984. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus. J. Gen. Virol. 65: 1395-1399.
53. Precheur B, Bossus M, Grass-Masse H, Quiniou E, Tartar A, Craescu CT. 1994. NMR and circular dichroic studies of the solution structure of conformationally constrained antigenic peptides. Eur. J. Biochem. 220: 415-425.
54. Robert-Hebmann V, Emiliani S, Jean F, Resnicoff M, Traincard F, Devaux C. 1992a. Clonal analysis of murine B-cell response to the human immunodeficiency virus type 1 (HIV-1)-gag p17 and p25 antigens. Mol. Immunol. 29: 729-738.
55. Robert-Hebmann V, Emiliani S, Resnicoff M, Jean F, Devaux C. 1992b. Subtyping of human immunodeficiency virus isolates with a panel of monoclonal antibodies: identification of conserved and divergent epitopes on p17 and p25 core proteins. Mol. Immunol. 29: 1175-1183.
56. Rwambo PM, Iseel CJ, Hussain KA, Montelaro RC. 1990. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV). Arch. Virol. 111: 275-280.
57. Salinovich O, Payne SL, Montelaro RC, Hussain KA, Issel CJ, Schnorr KL. 1986. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J. Virol. 57: 71-80.
58. Soutullo A, Verwimp V, Riveros M, Pauli R, Tonarelli G. 2000. Design and validation of an ELISA for equine infectious anemia (EIA) diagnosis using synthetic antigens. Vet. Microbiol. 2063: 1-11.
59. Sreerama N, Woody RW. 1993. A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal. Biochem. 209: 32-44.
60. Stephens RM, Casey JW, Rice NR. 1986. Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus. Science 231: 589-594.
61. Tencza SB, Islam KR, Kalia V, Nasir MS, Jolley ME, Montelaro RC. 2000. Development of a fluorescence polarization based diagnostic assay for equine infectious anemia virus. J. Clin. Microbiol. 38: 1854-1859.
62. Tonarelli GG, Lottersberger J, Salvetti JL, Jacchieri S, Silva-Lucca RA, Beltramini LM. 2000. Secondary structure-improved bioaffinity correlation in elongated and modified synthetic epitope peptides from p24 HIV-1 core protein. Lett. Pept. Sci. 5: 1-8.
63. Truong C, Brand D, Mallet F, Roingeard P, Barin F. 1997. Comparison of antibody responses to different forms of HIV-1 core antigens by epitope mapping. J. Med. Virol. 51(3): 145-151.
64. Worthylake DK, Wang H, Yoo S, Sunquist WI, Hill CP. 1999. Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution. Acta Crystallog. Sect. D 55: 85-92.
65. Zhang W, Lonning SM, McGuire TC. 1998. Gag protein epitopes recognizaed by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J. Virol. 72: 9612-9620.